Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.53% vs -7.69% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 75.00% vs -72.73% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 71.43% vs -22.22% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 40.20% vs 2.55% in Mar 2024
Compare Balance Sheet Results of Vaishali Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
26.09
13.88
12.21
87.97%
Share Warrants & Outstandings
Total Reserve
38.82
71.23
-32.41
-45.50%
Shareholder's Funds
64.92
85.10
-20.18
-23.71%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
7.36
0.45
6.91
1,535.56%
Secured Loans
7.36
0.00
7.36
0.00%
Unsecured Loans
0.00
0.45
-0.45
-100.00%
Deferred Tax Assets / Liabilities
-0.18
0.11
-0.29
-263.64%
Other Long Term Liabilities
0.42
0.00
0.42
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.26
0.43
-0.17
-39.53%
Total Non-Current Liabilities
4.69
1.00
3.69
369.00%
Current Liabilities
Trade Payables
27.14
21.24
5.90
27.78%
Other Current Liabilities
5.43
4.51
0.92
20.40%
Short Term Borrowings
7.46
0.37
7.09
1,916.22%
Short Term Provisions
0.01
0.06
-0.05
-83.33%
Total Current Liabilities
40.05
26.17
13.88
53.04%
Total Liabilities
109.66
112.27
-2.61
-2.32%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.46
119.40
-115.94
-97.10%
Less: Accumulated Depreciation
2.14
80.58
-78.44
-97.34%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.32
38.82
-37.50
-96.60%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.07
-0.07
-100.00%
Intangible assets under development
0.25
0.00
0.25
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.43
0.00
0.43
0.00%
Long Term Loans & Advances
1.05
2.51
-1.46
-58.17%
Other Non Current Assets
1.61
0.22
1.39
631.82%
Total Non-Current Assets
5.18
41.63
-36.45
-87.56%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.81
9.81
-5.00
-50.97%
Sundry Debtors
46.72
30.61
16.11
52.63%
Cash and Bank
1.84
26.23
-24.39
-92.99%
Other Current Assets
0.52
0.02
0.50
2,500.00%
Short Term Loans and Advances
50.59
3.96
46.63
1,177.53%
Total Current Assets
104.48
70.64
33.84
47.90%
Net Current Assets (Including Current Investments)
64.43
44.47
19.96
44.88%
Total Current Assets Excluding Current Investments
104.48
70.64
33.84
47.90%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
109.66
112.27
-2.61
-2.32%
Contingent Liabilities
0.00
18.03
-18.03
-100.00%
Total Debt
8.50
0.82
7.68
936.59%
Book Value per share (adjusted)
4.98
61.33
-56.35
-91.88%
Annual - Borrowings
Borrowings 11.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.53% vs -7.69% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 75.00% vs -72.73% in Mar 2024
Annual - Fixed Assets
Fixed Assets 1.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 71.43% vs -22.22% in Mar 2024
Annual - Investments
Investments 0.43 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 104.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.20% vs 2.55% in Mar 2024






